Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 09-Feb-23 8:11 PM View:  | Delaversano Robert J VP, Finance | Oncosec Medical Inc (ONCS) | 09-Feb-23 | Private Sale | 40 | $1.37 | $54.80 | (4%) 1.05K to 1.01K | |
| 04-Nov-22 8:21 PM View: | Delaversano Robert J VP, Finance | Oncosec Medical Inc (ONCS) | 04-Nov-22 | Sale | 283 | $0.37 | $104.71 | (1%) 23.26K to 22.98K | |
| 05-Aug-22 8:00 PM View: | Delaversano Robert J VP, Finance | Oncosec Medical Inc (ONCS) | 05-Aug-22 | Sale | 284 | $0.71 | $201.64 | (1%) 23.54K to 23.26K | |
| 06-May-22 12:35 PM View: | Delaversano Robert J VP, Finance | Oncosec Medical Inc (ONCS) | 06-May-22 | Market Sale | 274 | $0.83 | $227.42 | (1%) 23.82K to 23.54K | 1% |
| 11-Feb-22 8:00 PM View: | Delaversano Robert J VP, Finance | Oncosec Medical Inc (ONCS) | 09-Feb-22 | Market Sale | 409 | $0.88 | $359.92 | (2%) 24.23K to 23.82K | 7% |
| 03-Nov-21 8:00 PM View: | Delaversano Robert J VP, Finance | Oncosec Medical Inc (ONCS) | 01-Nov-21 | Market Sale | 343 | $1.75 | $600.25 | (1%) 24.57K to 24.23K | (6%) |
| 25-Aug-21 5:31 PM View: | Dalesandro Margaret Director | Oncosec Medical Inc (ONCS) | 23-Aug-21 | Market Purchase | 20,000 | $1.89 | $37,800.00 | 100% 0 to 20.0K | 11% |
| 24-Aug-21 8:03 PM View: | Zhao Yuhang Director | Oncosec Medical Inc (ONCS) | 23-Aug-21 | Market Purchase | 4,000 | $1.88 | $7,520.00 | 50% 8.0K to 12.0K | 7% |
| 24-Aug-21 8:03 PM View: | Zhao Yuhang Director | Oncosec Medical Inc (ONCS) | 20-Aug-21 | Market Purchase | 8,000 | $1.94 | $15,520.00 | 100% 0 to 8.0K | 4% |
| 03-Aug-21 8:14 PM View: | Delaversano Robert J VP, Finance | Oncosec Medical Inc (ONCS) | 02-Aug-21 | Market Sale | 412 | $2.18 | $898.16 | (2%) 24.98K to 24.57K | (2%) |
| 29-Jun-21 7:42 PM View: | Leuthner Brian A Interim CEO | Oncosec Medical Inc (ONCS) | 28-Jun-21 | Grant | 192,000 | -- | -- | 100% 0 to 192.0K | |
| 29-Jun-21 7:42 PM View: | Leuthner Brian A Interim CEO | Oncosec Medical Inc (ONCS) | 28-Jun-21 | Market Sale | 13,613 | $3.16 | $43,017.10 | (7%) 192.0K to 178.39K | |
| 04-May-21 8:00 PM View: | Delaversano Robert J VP, Finance | Oncosec Medical Inc (ONCS) | 03-May-21 | Market Sale | 453 | $4.86 | $2,201.58 | (2%) 25.43K to 24.98K | (4%) |
| 04-May-21 8:00 PM View: | O'Connor Daniel CEO and President Director | Oncosec Medical Inc (ONCS) | 30-Apr-21 | Market Sale | 3,172 | $4.86 | $15,415.90 | (3%) 99.27K to 96.1K | (4%) |
| 26-Apr-21 2:12 PM View: | China Grand Pharmaceutical ... 10% Owner | Oncosec Medical Inc (ONCS) | 16-Apr-21 | Private Purchase | 1,691,810 | $3.45 | $5,836,730.00 | 9% 18.47M to 20.16M | |
| 23-Feb-21 7:15 AM View: | Alpha Holdings, Inc. Director | Oncosec Medical Inc (ONCS) | 18-Feb-21 | Exercise (in-the money or at-the-money) | 368,250 | $3.45 | $1,270,460.00 | 27% 1.35M to 1.72M | |
| 02-Feb-21 8:00 PM View: | O'Connor Daniel CEO and President Director | Oncosec Medical Inc (ONCS) | 01-Feb-21 | Market Sale | 3,413 | $7.71 | $26,314.20 | (3%) 102.68K to 99.27K | < 1% |
| 03-Feb-21 9:42 PM View: | Delaversano Robert J Principal Accounting Officer | Oncosec Medical Inc (ONCS) | 01-Feb-21 | Grant | 8,750 | -- | -- | 52% 16.68K to 25.43K | |
| 27-Jan-21 12:18 PM View: | China Grand Pharmaceutical ... 10% Owner | Oncosec Medical Inc (ONCS) | 25-Jan-21 | Private Purchase | 4,067,040 | $5.45 | $22,165,400.00 | 28% 14.4M to 18.47M | |
| 23-Nov-20 8:33 PM View: | Alpha Holdings, Inc. Director | Oncosec Medical Inc (ONCS) | 20-Nov-20 | Market Sale | 80,000 | $4.92 | $393,872.00 | (6%) 1.43M to 1.35M | (27%) |
| 20-Nov-20 5:31 PM View: | Alpha Holdings, Inc. Director | Oncosec Medical Inc (ONCS) | 19-Nov-20 | Market Sale | 50,000 | $5.10 | $255,230.00 | (3%) 1.48M to 1.43M | (23%) |
| 19-Nov-20 5:00 PM View: | Alpha Holdings, Inc. Director | Oncosec Medical Inc (ONCS) | 18-Nov-20 | Market Sale | 10,999 | $5.24 | $57,652.40 | (< 1%) 2.98M to 2.97M | (19%) |
| 19-Nov-20 5:00 PM View: | Alpha Holdings, Inc. Director | Oncosec Medical Inc (ONCS) | 18-Nov-20 | Market Sale | 40,000 | $5.24 | $209,664.00 | (1%) 3.02M to 2.98M | (19%) |
| 18-Nov-20 1:50 PM View: | Alpha Holdings, Inc. Director | Oncosec Medical Inc (ONCS) | 17-Nov-20 | Market Sale | 40,000 | $5.17 | $206,744.00 | (3%) 1.57M to 1.53M | (21%) |
| 18-Nov-20 1:50 PM View: | Alpha Holdings, Inc. Director | Oncosec Medical Inc (ONCS) | 16-Nov-20 | Market Sale | 40,000 | $5.41 | $216,328.00 | (2%) 1.61M to 1.57M | (16%) |
| 03-Nov-20 8:04 PM View: | O'Connor Daniel CEO and President Director | Oncosec Medical Inc (ONCS) | 02-Nov-20 | Market Sale | 3,280 | $3.79 | $12,431.20 | (3%) 105.96K to 102.68K | (66%) |
| 21-Aug-20 5:05 PM View: | China Grand Pharmaceutical ... 10% Owner | Oncosec Medical Inc (ONCS) | 19-Aug-20 | Private Purchase | 2,398,800 | $3.25 | $7,796,100.00 | 20% 12.0M to 14.4M | |
| 04-Aug-20 9:21 PM View: | O'Connor Daniel CEO and President Director | Oncosec Medical Inc (ONCS) | 31-Jul-20 | Market Sale | 3,133 | $4.20 | $13,158.60 | (3%) 109.09K to 105.96K | (49%) |
| 03-Jun-20 9:05 PM View: | O'Connor Daniel CEO and President Director | Oncosec Medical Inc (ONCS) | 29-May-20 | Payment of Exercise | 44,471 | $2.23 | $99,170.30 | (29%) 153.57K to 109.09K | (181%) |
| 03-Jun-20 9:16 PM View: | Delaversano Robert J Principal Accounting Officer | Oncosec Medical Inc (ONCS) | 29-May-20 | Payment of Exercise | 8,679 | $2.23 | $19,354.20 | (34%) 25.36K to 16.68K | (181%) |
| 03-Jun-20 9:16 PM View: | Delaversano Robert J Principal Accounting Officer | Oncosec Medical Inc (ONCS) | 29-May-20 | Grant | 25,362 | -- | -- | 100% 0 to 25.36K | |
| 03-Jun-20 9:05 PM View: | O'Connor Daniel CEO and President Director | Oncosec Medical Inc (ONCS) | 29-May-20 | Grant | 90,580 | -- | -- | 144% 62.99K to 153.57K | |
| 04-May-20 6:07 PM View: | O'Connor Daniel CEO and President Director | Oncosec Medical Inc (ONCS) | 30-Apr-20 | Market Sale | 3,075 | $1.79 | $5,504.25 | (5%) 66.06K to 62.99K | (253%) |
| 21-Apr-20 8:00 PM View: | Dhillon Avtar S Director | Oncosec Medical Inc (ONCS) | 17-Apr-20 | Grant | 12,500 | $1.55 | $19,375.00 | 25% 49.55K to 62.05K | 302% |
| 03-Feb-20 8:00 PM View: | O'Connor Daniel CEO and President Director | Oncosec Medical Inc (ONCS) | 31-Jan-20 | Market Sale | 2,654 | $1.96 | $5,201.84 | (4%) 68.72K to 66.06K | (219%) |
| 21-Jan-20 4:15 PM View: | Bonstein Sara CFO/COO | Oncosec Medical Inc (ONCS) | 16-Jan-20 | Market Sale | 1,351 | $2.08 | $2,810.08 | (3%) 42.74K to 41.39K | (203%) |
| 01-Nov-19 8:00 PM View: | O'Connor Daniel CEO and President Director | Oncosec Medical Inc (ONCS) | 31-Oct-19 | Market Sale | 2,128 | $2.16 | $4,596.48 | (3%) 70.84K to 68.72K | (191%) |
| 18-Oct-19 8:00 PM View: | Bonstein Sara CFO/COO | Oncosec Medical Inc (ONCS) | 16-Oct-19 | Market Sale | 1,111 | $2.01 | $2,233.11 | (3%) 43.85K to 42.74K | (215%) |
| 02-Aug-19 6:00 PM View: | O'Connor Daniel CEO and President Director | Oncosec Medical Inc (ONCS) | 31-Jul-19 | Payment of Exercise | 2,156 | $2.23 | $4,807.88 | (3%) 73.0K to 70.84K | (184%) |
| 19-Jul-19 9:55 PM View: | Alpha Holdings, Inc. Director 10% Owner | Oncosec Medical Inc (ONCS) | 17-Jul-19 | Market Purchase | 30,000 | $2.57 | $77,100.00 | 2% 1.58M to 1.61M | 146% |
| 17-Jul-19 9:55 PM View: | Alpha Holdings, Inc. Director 10% Owner | Oncosec Medical Inc (ONCS) | 16-Jul-19 | Market Purchase | 60,000 | $2.34 | $140,400.00 | 4% 1.52M to 1.58M | 171% |
| 18-Jul-19 8:00 PM View: | Bonstein Sara CFO/COO | Oncosec Medical Inc (ONCS) | 16-Jul-19 | Payment of Exercise | 1,111 | $2.42 | $2,688.62 | (2%) 44.96K to 43.85K | (162%) |
| 17-Jul-19 9:55 PM View: | Alpha Holdings, Inc. Director 10% Owner | Oncosec Medical Inc (ONCS) | 15-Jul-19 | Market Purchase | 30,000 | $2.22 | $66,600.00 | 2% 1.49M to 1.52M | 185% |
| 24-May-19 5:30 PM View: | Alpha Holdings, Inc. Director 10% Owner | Oncosec Medical Inc (ONCS) | 22-May-19 | Market Purchase | 491,000 | $3.14 | $1,541,740.00 | 5% 10.0M to 10.49M | 100% |
| 02-May-19 4:15 PM View: | O'Connor Daniel CEO and President Director | Oncosec Medical Inc (ONCS) | 30-Apr-19 | Payment of Exercise | 21,357 | $0.56 | $12,066.70 | (3%) 751.35K to 729.99K | (11%) |
| 18-Apr-19 4:53 PM View: | Bonstein Sara CFO/COO | Oncosec Medical Inc (ONCS) | 16-Apr-19 | Payment of Exercise | 11,102 | $0.60 | $6,662.31 | (2%) 460.73K to 449.63K | (7%) |
| 01-Feb-19 9:00 PM View: | O'Connor Daniel CEO and President Director | Oncosec Medical Inc (ONCS) | 31-Jan-19 | Payment of Exercise | 25,318 | $0.88 | $22,279.80 | (3%) 776.67K to 751.35K | 27% |
| 18-Jan-19 8:45 PM View: | Bonstein Sara CFO/COO | Oncosec Medical Inc (ONCS) | 16-Jan-19 | Payment of Exercise | 13,379 | $0.69 | $9,164.62 | (3%) 474.11K to 460.73K | 5% |
| 27-Dec-18 9:00 PM View: | O'Connor Daniel CEO and President Director | Oncosec Medical Inc (ONCS) | 24-Dec-18 | Grant | 750,000 | -- | -- | 2812% 26.67K to 776.67K | |
| 17-Dec-18 5:55 PM View: | Demesa James M Director | Oncosec Medical Inc (ONCS) | 17-Dec-18 | Grant | 1,500 | $0.77 | $1,155.00 | 7% 21.0K to 22.5K | (17%) |
